anterior cerebrum (p<0.05), however, TNFα infusion had no effect on blood-brain barrier (BBB) 
mechanistic role to promote preeclampsia, the impact of TNFα on the cerebral vasculature 23 during pregnancy remains unclear. We tested the hypothesis that TNFα contributes to 24 cerebrovascular abnormalities during placental ischemia by first infusing TNFα in pregnant rats 25 (200 ng/day i.p, from gestational day 14 to 19), at levels to mimic those reported in preeclamptic 26 women. TNFα increased mean arterial pressure (MAP, p<0.05) and brain water content in the 27 anterior cerebrum (p<0.05), however, TNFα infusion had no effect on blood-brain barrier (BBB) 28 permeability in the anterior cerebrum or posterior cerebrum. We then assessed the role of 
47
Our lab previously demonstrated that placental ischemia leads to cerebral edema, impaired 48 myogenic reactivity in middle cerebral arteries (38), impaired whole-brain cerebral blood flow 49 autoregulation, and increased BBB permeability (51). The factors involved in placental 50 ischemia-induced cerebrovascular abnormalities remain unknown. One candidate that may link 51 placental ischemia to cerebrovascular abnormalities is tumor necrosis factor alpha (TNFα).
52
TNFα levels are increased both in the circulation (27) and placentas (25) of placental ischemic 53 rats and blockade of TNFα prevents the preeclampsia phenotype associated with this model (25).
54
Furthermore, when TNFα is infused at a level to mimic those reported in preeclamptic women, 55 mean arterial pressure (MAP) is elevated in normal pregnant rats (27) . While these studies 56 provide compelling evidence for the role of TNFα in the regulation of blood pressure, whether 57 placental ischemia-induced increases in TNFα contribute to cerebral edema and increases in 58 blood brain barrier permeability has not been established. Therefore, in this study, we determined 59 whether infusion of TNFα into normal pregnant rats contributes to cerebral edema and increased 60 blood-brain barrier permeability and whether blockade of TNFα in placental ischemic rats would 61 reverse these cerebrovascular changes. 
MATERIALS & METHODS

70
TNF infusion:
71
On gestational day 14, rats were anesthetized using 3% isoflurane, and osmotic mini-72 pumps were surgically implanted intraperitoneally for the constant infusion of recombinant 73 human TNFα at a dose of 200 ng/day. This dose led to an increase in circulating human TNFα 74 levels from 0.00 pg/mL to 0.78±0.26 pg/mL on gestational day 19. Non-pregnant rats were not 75 included because previous studies have shown that TNF infusion increases blood pressure in 76 pregnant rats but has no effect on blood pressure in non-pregnant rats. Tissues were collected on On gestational day 19, rats were euthanized under isoflurane anesthesia and brains were 96 removed and weighed. Cerebellum, anterior cerebrum (rostral to the middle cerebral artery), and 97 posterior cerebrum were weighed individually. Brain regions were then dried in an oven at 60°C 98 for 72 hours, after which they were re-weighed to obtain the dry weight. Brain water content was 99 then calculated as a percentage ((wet weight -dry weight)/ wet weight). To calculate cerebrum 100 water content, the sum of the anterior and posterior brain region weights were used.
101
Assessment of Cerebrovascular Permeability:
102
A separate group of pregnant rats were utilized for determination of cerebrovascular 103 permeability. Rats were subjected to either TNFα infusion or blockade, and jugular catheters hippocampi were also dissected. Brain regions were weighed and snap frozen in liquid nitrogen.
110
Tissue and plasma samples were processed as previously described (49, 54). Briefly, 1 mL TCA 111 (50%) was added to samples, homogenized, and sonicated followed by centrifugation at 10000 
116
Assessment of plasma albumin concentration:
117
Because of the Evans blue has been shown to bind to albumin, we measured plasma 118 albumin to determine whether there were any differences in the amount of circulating albumin 119 with TNFα infusion. A commercially available Rat Albumin ELISA kit (GenWay Biotech Inc.) 120 was used and run following manufacturer's directions.
121
Statistical Analysis:
122 Statistically significant differences between the normal pregnant and TNFα-treated 123 groups were determined using unpaired one-tailed t-test while Two-way analysis of variance was 124 used for the TNFα blockade study. All data were considered statistically different if p < 0.05.
125
GraphPad Prism was used for statistical analysis and generation of graphs. 
RESULTS
127
General Pregnancy Characteristics:
128
Infusion of recombinant human TNFα in pregnant rats resulted in a 10 mmHg increase 129 (99±1 to 109±3 mmHg) in mean arterial pressure (MAP) ( into pregnant rats had no effect on plasma albumin concentration ( Figure 2C ). 
165
Consistent with the brain water content data, a significant difference in BBB permeability 166 was not reported in the whole cerebrum ( Figure 5A) . However, when regional differences were evidence that the anterior cerebrum is also affected. Indeed, increased cerebral perfusion pressure 242 has been reported in both the anterior cerebral arteries of preeclamptic patients (37) and in the 243 anterior and middle cerebral arteries of severe preeclamptic patients (6). Other studies show that 244 while cortical/sub-cortical lesions were detected predominantly in the occipital lobe, the frontal 245 lobe was also affected (9). Importantly, a recent study demonstrated that white matter lesions 246 were more common among women with previous pregnancies complicated by preeclampsia or 247 eclampsia and that these lesions were most frequently observed in the frontal lobe (53).
248
Additionally, in animal models of acute hypertension during pregnancy, cerebral edema occurs 249 in both the anterior and posterior cerebrum (7). Taken together, these studies demonstrate that where edema was evident (51). We therefore hypothesized that placental ischemia failed to 
